Research Funded Project

Novel liposomal and polymeric nanoparticles for controlled transport and release of doxorubicin against triple negative breast cancer (TNBC) (LIPODOX)

Funding Organization: National/ESPA
Contract no.: Τ1ΕΔΚ-01833
Partners: DEMO Α.Ε.; Univ. of Athen; Univ. of Thessaly; FORTH / ICE-HT
Duration: From: 2018 - to: 2022
Researchers: Antimisiaris, S. (PI)
Year Period: 2018-2021
Type: national